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Alfonso Ferna´ndez-Mayoralas,2 and Juan J. Arago´n1*
Background: Urinary excretion of D-xylose by suckling
rats after ingestion of a mixture of 4-, 3-, and 2-galacto-
sylxyloses reflects lactase activity in vivo. We aimed to
select the most convenient of these disaccharides for
detecting changes of the enzyme activity in vivo and to
optimize the method.
Methods: 4-, 3-, and 2-Galactosylxyloses were synthe-
sized and purified, then orally administered to suckling
rats of different ages. D-Xylose was measured colori-
metrically by the phloroglucinol reaction in urine and
plasma. Lactase activity was determined in extracts of
small intestine mucosa with lactose, galactosylxyloses,
and phlorizin as substrates.
Results: D-Xylose appeared in the urine in a dose-
dependent manner after ingestion of any of the 3 galac-
tosylxylose disaccharides. Correlation between D-xylose
elimination and intestinal lactase activity was highest
with 4-galactosylxylose (r  0.97; n  24), lower with
2-galactosylxylose (r  0.89; n  24), and lowest with
3-galactosylxylose (r  0.34; n  23). The kinetic prop-
erties of intestinal lactase accounted for these differ-
ences. D-Xylose concentration in plasma after adminis-
tration of 4-galactosylxylose also correlated with lactase
activity (r  0.93; n  33).
Conclusions: 4-Galactosylxylose is the most suitable
compound for the evaluation of lactase activity in vivo.
Measurement of the derived D-xylose in either urine or
blood gives an estimate of the total lactose digestive
capacity of the small intestine. The optimized method
holds promise for development of a simple, low-cost,
and reliable new test for the noninvasive diagnosis of
hypolactasia.
© 2006 American Association for Clinical Chemistry
Lactase phlorizin hydrolase (EC 3.2.1.23) is an intestinal
brush border enzyme responsible for the hydrolysis of
lactose to galactose and glucose, which are absorbed by
the intestinal mucosa. Very low lactase activity, or hypo-
lactasia, leads to malabsorption of lactose, which leads to
symptoms of lactose intolerance, such as flatus, pain, and
diarrhea, after ingestion of milk or dairy products (1, 2 ).
This disorder can be caused by the genetically determined
adult-type hypolactasia, which affects over one half of the
world population and is predominantly found in non-
Caucasian people (3, 4 ). It can also be the result of the rare
congenital lactase deficiency and secondary hypolactasia
caused by atrophy or damage of the small intestine
mucosa (1, 2 ).
Evaluation of lactase activity can be performed directly
by measuring the enzyme activity in a small-intestine
biopsy or indirectly by noninvasive, diagnostic tests.
These methods rely on a load of lactose followed by
determination of plasma glucose and galactose (5, 6 ),
urinary galactose (7 ), or the breath concentrations of
H2 (5, 6, 8 ),
14CO2 (9 ), or
13CO2 (derived from
14C-lactose
or 13C-lactose, respectively) (10 ). Measurement of plasma
13C-glucose after consumption of 13C-lactose (11 ), or
of 13C/2H-glucose by simultaneously administering 2H-
glucose (12 ), has also been used. However, these methods
have important drawbacks such as (a) low reliability,
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because they can be influenced by many factors (3, 5, 6, 8 ),
as is well documented for the breath hydrogen test
(1, 6, 10–13); and (b) the abdominal discomfort produced
in intolerant patients by the unphysiologically high doses
of lactose [usually 50 (5–10) or 25 g (11, 12 )]. In some
cases, highly sophisticated equipment is required (10–12).
Therefore, a new method for evaluation is necessary.
We developed a new, noninvasive method based on
oral administration of 4-galactosylxylose, a close struc-
tural analog of lactose, which is hydrolyzed by intestinal
lactase yielding 2 physiologic products, galactose and
xylose (14, 15 ). d-Xylose is passively absorbed from the
small intestine (16, 17 ) and is accumulated in the urine
(14, 15 ), where it could be measured by a simple colori-
metric method (18 ). To overcome the complexity and
inefficiency of the chemical synthesis of 4-galactosylxy-
lose, we carried out an enzymatic synthesis involving
only 1 reaction step (19 ), which produced a final prepa-
ration with high yield, but consisting of a mixture of 2-, 3-,
and 4-galactosylxyloses (Fig. 1), although urinary excre-
tion of d-xylose followed administration of this mixture
(19 ). Distinct kinetic properties of the 3 regioisomers,
observed with lamb intestinal lactase in vitro (19 ), sug-
gested that they could behave differently in vivo.
In view of the potential advantages of this method, we
examined the efficiency of each of the 3 galactosylxylose
disaccharides in detecting the changes of rat lactase
activity in vivo, so that we might select the one most
suitable for noninvasive evaluation of the enzyme.
Materials and Methods
chemicals
Phlorizin, phloretin, sugars, and phloroglucinol (1, 3, 5-
trihydroxybenzene) were from Sigma. All other chemicals
were from commercial sources and were of analytical
grade.
synthesis of galactosylxyloses
The synthesis of 4-, 3-, and 2-O--d-galactopyranosyl-d-
xylose disaccharides (4-, 3-, and 2-galactosylxylose, re-
spectively) was performed in 1 reaction step by enzymatic
-d-galactosylation of d-xylose, following our previous
work on this topic (19–21). Nevertheless, further modifi-
cations were introduced to obtain pure disaccharides in
gram scale that might facilitate a simple and inexpensive
scaling up of their production (G. Corrales, C. Hermida,
J.J. Arago´n, F.J. Can˜ada, and A. Ferna´ndez-Mayoralas,
unpublished manuscript). Purity was above 98% for
4-galactosylxylose and 90% for 3- and 2-galactosylxy-
lose, as assessed by gas chromatography.
animals
Sprague–Dawley rats were purchased from Harlan and
housed at the animal facilities of the Medical School of
Universidad Auto´noma de Madrid. We followed the
institution’s guide with register no. EX-021-U for the care
and use of laboratory animals, which conforms to guide-
lines issued by the European Economic Community [Jour-
nal Officiel des Communaute´s Europe´ennes (De´c 18)
1986; L358/26].
Fig. 1. Chemical structures of the galactosylxyloses used in this work.
The structure of lactose is included for comparison.
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administration of galactosylxyloses to
animals and sample collection
Suckling rats 12–35 days of age were fasted for 6 h in
metabolic cages at 30 °C and received an oral gavage of
0.3 mL of an aqueous solution containing the disacchar-
ides or d-xylose. Urine was collected by intermittent
transabdominal bladder pressure before and at the time
indicated after administration of the compound. Blood
samples of 0.4 mL were obtained via cardiac puncture,
and plasma was immediately separated by centrifugation
at 1000g for 5 min. Urine and plasma samples were stored
at 20 °C until analyzed.
measurement of d-xylose
Unless otherwise indicated, d-xylose was determined
colorimetrically with phloroglucinol (18 ), except that the
final reaction volume was 1 mL. Absorbance at 554 nm
was measured in a Perkin-Elmer Lambda 5 spectropho-
tometer. In some experiments, a micromethod was also
used for d-xylose determination, using nonsterile, 96-well
plates resistant to acid and heat (polypropylene plates;
Costar). Each well contained 190 L of the color reagent
(0.5 g of phloroglucinol, 100 mL of glacial acetic acid, and
10 mL of concentrated hydrochloric acid) and up to 10 L
of the sample in a final volume of 200 L. The plate was
sealed with ThermowellTM (Costar), and the reaction was
allowed to proceed for 20 min at 100 °C in an oven
(Heraeus Model T5042E) and then stopped by a 10-min
incubation at 4 °C. Absorbance at 554 nm was read in a
microtiter plate reader (Molecular Devices; Model EL340).
d-Xylose determination could be carried out with confi-
dence within a linear interval of 0.25 to 20.0 g of this
compound (r  0.99). In some experiments, d-xylose was
also determined by gas chromatography as described
below.
assay of intestinal lactase activity
To measure rat intestinal lactase, the mucosa from the
medium region of the small intestine was obtained as
described (14 ) and homogenized with 10 volumes of
100 mmol/L sodium maleate buffer, pH 6.0. Lactase
activity was determined in the homogenate, designated
the extract, as described (14 ) by measuring the released
galactose with galactose dehydrogenase (22 ). One unit of
enzyme activity is defined as the amount of enzyme
catalyzing the conversion of 1 mol of substrate/min at
25 °C.
To study the kinetic properties of rat intestinal lactase
with 4-, 3-, and 2-galactosylxylose and lactose, substrate
hydrolysis was evaluated as the xylose (from galacto-
sylxyloses) or galactose (from lactose) released, measured
by gas chromatography as follows. Samples (50 L) of the
assay mixture were removed at 0, 10, and 20 min, then
boiled for 2 min, frozen, and lyophilized. The dry residue
was dissolved in pyridine (20 L) containing 1 mmol/L
benzyl -xyloside as internal standard, and 20 L of the
derivatizing agent trymethylsilylimidazol was added. Af-
ter sonication for 60 s and incubation for 30 min at 60 °C,
1–2 L of sample was injected on a glass capillary column
ultra-2 [12 m  0.2 mm (i.d.)] attached to a flame
ionization detector (Hewlett-Packard Model 5890).
The phlorizin hydrolase activity of intestinal lactase
was measured in a reaction mixture containing 50
mmol/L sodium phosphate, pH 6.0; 10 mol/L phlorizin;
and 10 L of extract in a final volume of 200 L. The
phloretin released was determined as described (23 ).
Protein concentration was determined as described (24 ).
statistics
Results are presented as the mean (SE). Correlations were
determined by linear regression analysis (least-squares
method). Statistical significance was set at P 0.05.
Results
time course and dose dependence of the
urinary elimination of d-xylose derived from
4-galactosylxylose
As shown in Fig. 2, oral administration of 16 mg of
4-galactosylxylose to suckling rats led to progressive
elimination of d-xylose in the urine, which reached a peak
3 h after ingestion of the disaccharide and was completed
after 7 h, so that 98% of the pentose accumulated in the
urine after 6 h. The latter time was selected as the optimal
period for urine collection.
Elimination of urinary d-xylose increased linearly with
increasing doses (from 2 to 32 mg) of the disaccharide (see
Table 1 in the Data Supplement that accompanies the
online version of this article at http://www.clinchem/
content/vol52/issue2). However, the percentage of D-
xylose eliminated was similar for all doses, averaging
Fig. 2. Elimination of D-xylose in the urine of suckling rats after oral
administration of 4-galactosylxylose.
Four suckling rats of the same litter and age (15 days) were orally administered
16 mg of 4-galactosylxylose. Urine was collected at the time indicated after
administration of the disaccharide, and D-xylose was determined in the urine
samples colorimetrically. Plotted points represent means (SE; error bars) of
D-xylose eliminated in each sample () and in cumulative urine (●). In some
cases, the SE of the means does not exceed the height of the symbols.
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22.8 (0.4)% of the administered amount of 4-galactosylxy-
lose. Similar results were obtained with 3- and 2-galacto-
sylxylose (data not shown), indicating that they are also
substrates of intestinal lactase in vivo. Therefore, the
disaccharide dose could be reduced to at least 4 mg for
highly confident measurements of urinary d-xylose.
When 1, 2, 4, 8, and 16 mg of d-xylose were given to
suckling rats 15, 18, and 30 days of age (4 animals for each
dose and age), the proportion of the pentose recovered in
the urine averaged 52.1 (0.1)% of the amount given, being
independent of dose and age. This percentage was above
that of the urinary d-xylose resulting from 4-galactosylxy-
lose [22.8 (0.4)%], indicating that d-xylose uptake was not
saturated under the conditions in Table 1 in the online
Data Supplement. Endogenous metabolization may ac-
count for most of the remainding 48% of administered
d-xylose. In humans, d-threitol is the main end product of
d-xylose catabolism (25 ), but the exact metabolic pathway
is unknown in mammals.
correlation between urinary elimination of
d-xylose derived from 4-, 3-, and 2-
galactosylxylose and lactase activity
Fig. 3 shows how d-xylose elimination in 6-h urine after
administration of 4 mg of each galactosylxylose to suck-
ling rats correlates with the physiologic decrease of lac-
tase activity measured directly in intestinal mucosa ex-
tracts along animal growth. As seen in Fig. 3A, d-xylose
elimination reached a maximum of 22% at the 15th day
with either disaccharide, followed by a gradual decrease,
which was highly different with the 3 compounds. The
pattern of 4-galactosylxylose reflected the normal de-
crease of lactase activity in the postweaning period,
whereas the decrease of d-xylose elimination was lower
than the enzyme decrease with 2-galactosylxylose and
much lower with 3-galactosylxylose, so that the urinary
pentose excretion at day 35 diminished by 65.6 (2.1)% and
42.2 (1.8)%, respectively, compared with the values at day
15. In contrast, 4-galactosylxylose elicited a decrease of
93.1 (0.3)% during the same period, which practically
coincided with that of lactase activity [93.7 (0.5)%]. There-
fore, correlation between d-xylose elimination and lactase
activity was the highest with 4-galactosylxylose, lower
with 2-galactosylxylose, and very low with 3-galacto-
sylxylose (Fig. 3B).
kinetic characteristics of rat intestinal
lactase with galactosylxylose disaccharides
The different behaviors of the 3 galactosylxyloses in vivo
suggested that intestinal lactase hydrolyzed them with
distinct catalytic efficiencies. This was tested by determin-
ing the kinetic parameters of the enzyme for these sub-
strates and for lactose. As demonstrated in Table 1, rat
lactase exhibited the highest affinity for 3-galactosyl-
xylose (Km 8.5 mmol/L) and the lowest for 4-galactosyl-
xylose (Km 58.8 mmol/L), which also yielded the lowest
Vmax value (11% of that with lactose). Thus, the Vmax/Km
ratio indicated a much lower specificity of the enzyme for
4-galactosylxylose (3.5% with respect to that for lactose)
than for 3-galactosylxylose, which gave a ratio (187%)
even higher than lactose. The kinetic properties with
2-galactosylxylose were somewhere in between those
found with the 2 other regioisomers.
The marked differences observed in the kinetic behav-
iors of 4- and 3-galactosylxylose led us to analyze the
contribution of the 2 catalytic activities of the enzyme,
Fig. 3. Elimination of D-xylose in the urine of suckling rats after oral administration of 4-galactosylxylose (4GX), 3-galactosylxylose (3GX), and
2-galactosylxylose (2GX), and intestinal lactase activity as a function of age.
(A), a distinct group of suckling rats from 2 different litters and of the same age (12 days) was used for each disaccharide. These groups were composed of 24 animals
each for 4GX and 2GX, and of 23 animals for 3GX. Rats were orally administered 4 mg of the corresponding disaccharide. D-Xylose derived from 4GX (●), 3GX (Œ), or
2GX (f) and eliminated in the first 6-h urine collected after disaccharide administration was determined. The intestinal lactase activity () was determined post-mortem
in 4 rats from each group of animals, except for the group that received 3GX, in which 3 animals were killed on the day 12. The remaining animals were returned to
maternal nursing, and the experiment was repeated at the indicated age until all the rats were killed. Urinary D-xylose in each group of animals was determined in 20,
20, 16, 12, 8, and 4 rats at the age points of day 12, 15, 18, 21, 26, and 35, respectively. D-Xylose elimination is represented as a percentage of the amount of the
administered disaccharide. Data at each age point are given as means (SE) of 4 to 20 animals for D-xylose elimination and of 11–12 animals for lactase activity. (B),
linear regression analysis of urinary D-xylose after oral administration of each disaccharide and intestinal lactase activity. For 3GX (top), regression equation is y 
26.14x  15.71; r  0.34 (r2  12%); n  23; P 0.1. For 2GX (middle), regression equation is y  74.39x  9.18; r  0.89 (r2  79%); n  24; P 0.0001. For
4GX (bottom), regression equation is y  104.93x  0.12; r  0.97 (r2  93%); n  24; P 0.0001.
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lactase and phlorizin hydrolase, to the hydrolysis of both
substrates in vivo. We investigated this by determining
urinary d-xylose in suckling rats after giving them in-
creasing concentrations of glucal, a competitive inhibitor
of the enzyme at the lactose site (23 ), mixed with either 4
mg of 4-galactosylxylose or 1 mg of 3-galactosylxylose. As
shown in Fig. 4A, d-xylose elimination was inhibited
maximally above 50–100 mmol/L glucal, decreasing no
more than 40% from 4-galactosylxylose and 75% from
3-galactosylxylose. This suggested that a major propor-
tion of 4-galactosylxylose is split at the phlorizin hydro-
lase site, whereas most of 3-galactosylxylose is split at the
lactose site. Accordingly, in vitro studies with rat intesti-
nal lactase (Fig. 4B) revealed that inhibition of 4-galacto-
sylxylose hydrolysis was not higher than 35%, with a
minimal effect on phlorizin hydrolysis, whereas inhibi-
tion of 3-galactosylxylose hydrolysis reached 74%, close to
the 84% decrease of lactose hydrolysis. Because the lactose
site splits glycosides with hydrophilic aglycons, whereas
the phlorizin site preferentially splits glycosides with
hydrophobic aglycons (1 ), these findings suggest that the
lack of the HO-6 group in 4-galactosylxylose provides a
more hydrophobic environment for enzyme binding,
thereby restraining its interaction with the lactose site.
noninvasive evaluation of intestinal lactase
activity with 4-galactosylxylose by measuring
d-xylose in plasma
As seen in Fig. 5A, d-xylose markedly accumulated in
plasma after administration of 16 mg of 4-galactosylxy-
lose to suckling rats, reaching a maximum 3 h after the
oral gavage and gradually diminishing to values close to
the initial concentrations after 6 h. When 4, 8, and 16 mg
of 4-galactosylxylose were given to suckling rats (15 days
of age from 2 litters and using 4 animals for each dose),
the mean (SE) concentration of d-xylose in 3-h plasma
increased linearly and corresponded to 3.6 (0.5), 11.7 (0.6),
and 22.0 (1.1) g/100 L, respectively.
As shown in Fig. 5B, as observed with the urinary
pentose, the concentrations of d-xylose determined in
plasma 3 h after administration of 8 mg of 4-galactosylxy-
lose to suckling rats correlated strongly with lactase
activity determined directly in intestinal mucosa samples
obtained post mortem.
determination of d-xylose by other methods
The concentrations of d-xylose in both 3-h plasma and 6-h
urine from suckling rats 15 and 30 days of age that
received 4-galactosylxylose under conditions similar to
those shown in Figs. 3 and 5B, were also determined by
gas chromatography and by a micromethod developed to
measure the phloroglucinol reaction with a microtiter
plate reader using 96-well plates, as described in the
Materials and Methods. Both procedures gave results sim-
ilar to those described above (data not shown). The
phloroglucinol microassay not only facilitated the simul-
Table 1. Kinetic parameters for intestinal lactase
substrates.a
Substrate Km, mmol/L Vmax, U/mg protein Vmax/Km,
b %
Lactose 17.9 0.322 100.0
2-Galactosylxylose 22.2 0.111 27.8
3-Galactosylxylose 8.5 0.285 186.9
4-Galactosylxylose 58.8 0.037 3.5
a Kinetic parameters were determined as described in Materials and Methods.
Lactase activity was assayed in intestinal mucosa extracts of suckling rats
without further purification to approach physiologic conditions.
b Vmax/Km ratios for galactosylxyloses are indicated relative to the value
obtained for lactose.
Fig. 4. Effect of glucal on the in vivo (A) and in vitro (B) intestinal lactase
phlorizin hydrolase activity of suckling rats.
(A), 40 suckling rats of 4 different litters and of the same age (15 days) were
orally administered either 4 mg of 4-galactosylxylose (43 mmol/L; ●) or 1 mg of
3-galactosylxylose (11 mmol/L; Œ) and the indicated concentration of glucal in
0.3 mL of water. D-Xylose eliminated in the first 6-h urine after administration of
the corresponding disaccharide and glucal was determined. Urinary D-xylose is
represented as a percentage of the amount of the administered galactosylxy-
lose. Data are given as means (SE) of 4 animals. Similar results were obtained
with 4-galactosylxylose if glucal was administered 15 or 30 min before the
disaccharide. (B), intestinal lactase-phlorizin hydrolase activity assayed in vitro at
30 mmol/L lactose (f), 15 mmol/L 3-galactosylxylose (Œ), 60 mmol/L 4-galac-
tosylxylose (●), or 0.01 mmol/L phlorizin (), and in the presence of increasing
concentrations of glucal. The concentrations of substrates used in A and B were
close to their Km values (Table 1) (23).
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taneous performance of numerous measurements, but
also allowed us to use a considerably smaller volume of
sample (10 L).
Discussion
In this study, we have optimized a new method in
experimental animals based in the measurement of d-
xylose in either urine or blood after ingestion of the
synthetic lactose analog 4-galactosylxylose. This com-
pound was obtained with high purity after enzymatic
synthesis and was compared with the regioisomers 3-
and 2-galactosylxylose, which are also produced by this
procedure. The 3 disaccharides behaved as substrates
of intestinal lactase in vivo and yielded the same percent-
age of urinary d-xylose, 22%, when administered at
doses of 2–32 mg to 15-day-old rats, which had the
highest enzyme activity (Fig. 3). This value indicated that
the entire oral dose of galactosylxylose was hydrolyzed
by the intestinal enzyme, because it practically coincided
with the percentage of d-xylose (23%) expected from
100% hydrolysis, as the urinary recovery of d-xylose was
52% of the pentose given and the d-xylose moiety ac-
counts for 45% of the disaccharide molecular weight.
However, 4-galactosylxylose was the most effective com-
pound to evaluate lactase activity in vivo, as it elicited the
highest correlation (r  0.97) between urinary elimination
of d-xylose and the physiologic decrease of the enzyme
activity. The kinetic behavior of rat intestinal lactase with
the 3 regioisomers accounted for their different behaviors
in vivo. Inasmuch as the highest specificity constant
(taken as the Vmax/Km ratio) was obtained with 3-galac-
tosylxylose (Table 1), the catalytic efficiency in vivo was
high enough to hydrolyze a relatively high proportion of
this disaccharide even when the enzyme activity was
lowest (day 35). Consequently, d-xylose excretion de-
creased after weaning to a degree lower than that of
enzyme activity. The opposite was the case of 4-galacto-
sylxylose, for which the low specificity constant allowed
the change of both measurements to a similar extent.
Paradoxically, it is the worst substrate that turned out to
be most suitable to detect the changes in lactase activity in
vivo with high reliability. These results agree with previ-
ous reports on the role of each hydroxyl group of the
lactose molecule in its interaction with intestinal lactase
isolated from lambs (26, 27 ).
We obtained evidence that the rate-limiting step in the
overall absorption of d-xylose from 4-galactosylxylose is
not its transport but the hydrolysis of the disaccharide by
lactase, and that this compound does not permeate the
intestinal mucosa, as reported for lactose (1, 28 ). This was
shown by the strong correlation between d-xylose from
4-galactosylxylose and intestinal lactase activity, and also
by the fact that 100% of the disaccharide was hydrolyzed
in vivo when administered at the age of maximal lactase
content (day 15).
We found that evaluation of lactase activity in vivo
with 4-galactosylxylose can also be carried out by mea-
suring d-xylose in plasma, as indicated by the high
correlation between the plasma concentrations of the
pentose and enzyme activity (r  0.93; Fig. 5B). This
provides an alternative to urine d-xylose measurement,
especially in young children and infants, from whom
collection of urine can be troublesome. Additionally,
determination of blood d-xylose in combination with its
urinary content has been shown to improve the accuracy
of the d-xylose testing of intestinal absorption (17, 29 ), as
other factors such as renal dysfunction, delayed gastric
emptying, or portal hypertension can give falsely low
urinary d-xylose values.
The present method is a simple, low-cost, rapid color-
imetric test requiring only routinely available equipment.
Additionally, d-xylose determination by the phlorogluci-
nol reaction (18 ) is highly sensitive, so that 0.25 g of the
Fig. 5. Time course of plasma D-xylose in suckling rats after oral
administration of 4-galactosylxylose (A), and correlation with intestinal
lactase activity as a function of age (B).
(A), 20 rats from 2 litters and of the same age (15 days) were orally administered
16 mg of 4-galactosylxylose. Blood samples were obtained via cardiac puncture
at the indicated times, and D-xylose was determined in plasma. Data are given as
means (SE) of 3 to 5 animals at each time point. (B), 70 rats from 6 different
litters and of the same age (12 days) were used. At each age point, blood
samples were obtained from a group of 10 to 15 animals before and 3 h after the
oral administration of 8 mg of 4-galactosylxylose. D-xylose was determined in
plasma (●), and intestinal lactase activity () was determined post mortem in 5
to 6 animals of the same group. A disaccharide dose of 8 mg was used instead
of the 4-mg dose used for urine collection, as the quantities of D-xylose detected
in plasma are lower than in urine samples. Data are given as means (SE). (Inset),
linear regression analysis of plasma D-xylose concentrations and lactase activity.
Regression line: y  81.31x  0.42; r  0.93 (r2  86%); n  33; P 0.0001.
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pentose can be confidently detected. Consequently, reli-
able measurements could be made even in a decrease in
lactase of more than 90%, such as that observed in
35-day-old rats, by either urine or plasma determinations.
This suggests that the dose of disaccharide administered
to humans could be lower in comparison with other
noninvasive tests and, therefore, with a possible reduction
of abdominal discomfort in hypolactasia patients. Al-
though gastrointestinal symptoms after lactose loading
can be of help for further treatment, they are unreliable as
a diagnostic test (2, 3, 6, 8, 9 ) and provide no information
on the ability of the intestine to digest smaller, more
physiologic quantities of lactose. In contrast, measure-
ment of d-xylose in the urine or plasma reflects the overall
lactase activity in vivo, indicating the total lactose diges-
tive capacity of the small intestine. This can be an inter-
esting advantage over enzyme activity data obtained from
biopsy specimens, usually taken from the proximal small
intestine, where lactase is low (30, 31 ), in addition to the
possible uneven expression of the enzyme (1, 32 ).
Single-nucleotide polymorphisms upstream from the
lactase gene have been associated with adult-type hypo-
lactasia (33, 34 ) and tested to identify individuals with
genetic disposition for this disorder (35, 36 ). A functional
test of lactase activity is essential, however, for proper
assessment of patient situation because both residual
enzyme activity and clinical symptoms can vary within an
ample range, and low lactase activity can have other
causes.
The simplicity of the synthesis of 4-galactosylxylose,
requiring neither toxic nor expensive chemicals (19–21),
is another innovative aspect of this methodology. In fact,
toxicology studies have revealed that the synthetic di-
saccharide is devoid of apparent side effects in animals
(data not shown). The method optimized in this work is,
therefore, ready for clinical trials, so that it might be
applied within the primary healthcare system as a conve-
nient, noninvasive new test for diagnosis of hypolactasia.
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